Mitofusin 1 and 2 overexpression reduces AβO-mediated ER stress and apoptosis in N2a APPswe cells

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by amyloid beta oligomers (AβO).
• AβO are toxic, inducing mitochondrial dysfunction and endoplasmic reticulum (ER) stress.
• Mitofusins (Mfn1 and Mfn2) are key proteins in mitochondrial fusion, with Mfn2 also regulating ER function.

Purpose of the Study:

• To investigate the role of Mfn1 and Mfn2 in ER stress induced by AβO.
• To determine if Mfn1 and Mfn2 can mitigate AβO-mediated cellular toxicity and apoptosis.

Main Methods:

• Utilized N2a APPswe cells, a mouse neuroblastoma cell line overexpressing the Swedish mutation of amyloid precursor protein.
• Assessed cellular toxicity, ER stress markers, ER expansion, and apoptosis following Aβ exposure.
• Examined the effects of Mfn1 and Mfn2 overexpression on these parameters.

Main Results:

• Amyloid beta (Aβ) exposure caused toxicity, upregulated ER stress proteins, and ER expansion in N2a APPswe cells.
• Overexpression of Mfn1 and Mfn2 significantly reduced AβO-mediated ER stress.
• Mfn1 and Mfn2 overexpression also led to decreased apoptosis in the treated cells.

Conclusions:

• Mfn1 and Mfn2 play protective roles by reducing ER stress and apoptosis in the context of AβO toxicity.
• These findings suggest Mfn1 and Mfn2 as potential therapeutic targets for Alzheimer's disease.
• Further research into Mfn1 and Mfn2 mechanisms in AD pathogenesis is warranted.